DK2024748T3 - Monoklonale anti-annexin A3-antistoffer til påvisning af prostatacarcinomer - Google Patents

Monoklonale anti-annexin A3-antistoffer til påvisning af prostatacarcinomer

Info

Publication number
DK2024748T3
DK2024748T3 DK07725949.7T DK07725949T DK2024748T3 DK 2024748 T3 DK2024748 T3 DK 2024748T3 DK 07725949 T DK07725949 T DK 07725949T DK 2024748 T3 DK2024748 T3 DK 2024748T3
Authority
DK
Denmark
Prior art keywords
annexin
antibodies
detection
monoclonal anti
prostate carcinomas
Prior art date
Application number
DK07725949.7T
Other languages
Danish (da)
English (en)
Inventor
Andre Schrattenholz
Original Assignee
Proteosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteosys Ag filed Critical Proteosys Ag
Application granted granted Critical
Publication of DK2024748T3 publication Critical patent/DK2024748T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK07725949.7T 2006-06-09 2007-06-11 Monoklonale anti-annexin A3-antistoffer til påvisning af prostatacarcinomer DK2024748T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US85948906P 2006-11-17 2006-11-17
PCT/EP2007/005134 WO2007141043A2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma

Publications (1)

Publication Number Publication Date
DK2024748T3 true DK2024748T3 (da) 2013-03-18

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07725949.7T DK2024748T3 (da) 2006-06-09 2007-06-11 Monoklonale anti-annexin A3-antistoffer til påvisning af prostatacarcinomer

Country Status (13)

Country Link
US (1) US8012697B2 (enExample)
EP (1) EP2024748B1 (enExample)
JP (1) JP2009540278A (enExample)
KR (1) KR20090023372A (enExample)
AU (1) AU2007256377B2 (enExample)
CA (1) CA2654330A1 (enExample)
DE (1) DE07725949T1 (enExample)
DK (1) DK2024748T3 (enExample)
ES (1) ES2396730T3 (enExample)
PL (1) PL2024748T3 (enExample)
PT (1) PT2024748E (enExample)
RU (1) RU2467335C2 (enExample)
WO (1) WO2007141043A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
JP2012503634A (ja) * 2008-09-26 2012-02-09 プロテオシス アクチエンゲゼルシャフト 天然のアネキシンａ３を認識する新規抗体
FR2968767B1 (fr) 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) * 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
US9487831B2 (en) * 2013-09-12 2016-11-08 Versitech Limited Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
EP1724586A3 (en) 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
DE07725949T1 (de) 2009-07-02
WO2007141043A3 (en) 2008-03-20
EP2024748B1 (en) 2012-12-12
WO2007141043A2 (en) 2007-12-13
RU2467335C2 (ru) 2012-11-20
US8012697B2 (en) 2011-09-06
AU2007256377A1 (en) 2007-12-13
US20100233160A1 (en) 2010-09-16
JP2009540278A (ja) 2009-11-19
ES2396730T3 (es) 2013-02-25
EP2024748A2 (en) 2009-02-18
CA2654330A1 (en) 2007-12-13
AU2007256377B2 (en) 2012-11-01
PL2024748T3 (pl) 2013-05-31
KR20090023372A (ko) 2009-03-04
PT2024748E (pt) 2013-01-16
RU2008152009A (ru) 2010-07-20

Similar Documents

Publication Publication Date Title
DK3421498T3 (da) Monoklonale antistoffer mod claudin-18 til behandling af cancer
IL284991A (en) Antibodies against cd38 for treatment of multiple myeloma
PL2178921T3 (pl) Monoklonalne przeciwciała przeciwko glipikanowi-3
NO344963B1 (no) Humanisert antistoff
DK2019840T3 (da) Antagonist anti-human CD40 monoklonalt antistof.
NO20190202A1 (no) Anvendelse av anti-CGRP antagonist antistoff
DK3401334T5 (da) Monoklonale antistoffer mod claudin-18 til cancerbehandling
CR20170001A (es) Anticuerpos anti factor d humanizados
DK2902690T3 (da) Anomalidetektor til rørledninger
PL3059246T3 (pl) Zmodyfikowany region stały przeciwciała
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
DK3332808T3 (da) Humaniserede L243-antistoffer
ZA201000049B (en) Monoclonal antibeta amyloid antibody
SG10201404801YA (en) Monoclonal antibody
EP2324359A4 (en) MONOCLONAL ANTIBODY STRO-4
BRPI0908508A2 (pt) anticorpo monoclonal nkg2a anti-humano humanizado
ATE483732T1 (de) Madcam-antikörper
EP1761566A4 (en) HUMANIZED MONOCLONAL ANTI-DAY-72 ANTIBODIES
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
FI20075278A0 (fi) Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
DK3199180T3 (da) Epha3-antistoffer til behandlingen af faste tumorer
DK2024748T3 (da) Monoklonale anti-annexin A3-antistoffer til påvisning af prostatacarcinomer
FI20075251A0 (fi) Immunomääritys epästabiilien antigeenien määrittämiseksi
DK2094728T3 (da) Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer
SI2184605T1 (sl) Imunološki test z dvojnim prepoznavanjem za detekcijo protiteles